Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHA:600436)
China
· Delayed Price · Currency is CNY 200.48
-0.32 (-0.16%)
Jun 27, 2025, 3:00 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Liver Disease Medication | 4.46B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Liver Disease Medication Growth | 24.26% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical Circulation | 4.20B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical Circulation Growth | 3.60% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cosmetics | 706.76M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cosmetics Growth | 11.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cardiovascular and Cerebrovascular Medication | 265.75M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cardiovascular and Cerebrovascular Medication Growth | 60.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Business | 22.31M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Business Growth | 14.28% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 395.59M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 76.53% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cosmetics and Daily Chemical | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cosmetics and Daily Chemical Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Food | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Food Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Respiratory System Medication | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Respiratory System Medication Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Dermatology Medication | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Dermatology Medication Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cold Medicine | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cold Medicine Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Orthopedics Medicines | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Anorectal Medicine | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Anorectal Medicine Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
China | 9.60B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China Growth | 15.78% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Overseas | 457.64M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Overseas Growth | 13.95% |
Log In |
Log In |
Log In |
Log In | Upgrade
|